Berger-Höger Birte, Liethmann Katrin, Mühlhauser Ingrid, Haastert Burkhard, Steckelberg Anke
University of Hamburg, MIN-Faculty, Unit of Health Sciences and Education, Martin-Luther-King-Platz 6, D-20146, Hamburg, Germany.
mediStatistica Neuenrade, Lambertusweg 1b, D-58809, Neuenrade, Germany.
Trials. 2015 Oct 12;16:452. doi: 10.1186/s13063-015-0991-8.
Women with breast cancer want to participate in treatment decision-making. Guidelines have confirmed the right of informed shared decision-making. However, previous research has shown that the implementation of informed shared decision-making is suboptimal for reasons of limited resources of physicians, power imbalances between patients and physicians and missing evidence-based patient information. We developed an informed shared decision-making program for women with primary ductal carcinoma in situ (DCIS). The program provides decision coaching for women by specialized nurses and aims at supporting involvement in decision-making and informed choices. In this trial, the informed shared decision-making program will be evaluated in breast care centers.
METHODS/DESIGN: A cluster randomized controlled trial will be conducted to compare the informed shared decision-making program with standard care. The program comprises an evidence-based patient decision aid and training of physicians (2 hours) and specialized breast care and oncology nurses (4 days) in informed shared decision-making. Sixteen certified breast care centers will be included, with 192 women with primary DCIS being recruited. Primary outcome is the extent of patients' involvement in shared decision-making as assessed by the MAPPIN-Odyad (Multifocal approach to the 'sharing' in shared decision-making: observer instrument dyad). Secondary endpoints include the sub-measures of the MAPPIN-inventory (MAPPIN-Onurse, MAPPIN-Ophysician, MAPPIN-Opatient, MAPPIN-Qnurse, MAPPIN-Qpatient and MAPPIN-Qphysician), informed choice, decisional conflict and the duration of encounters. It is expected that decision coaching and the provision of evidence-based patient decision aids will increase patients' involvement in decision-making with informed choices and reduce decisional conflicts and duration of physician encounters. Furthermore, an accompanying process evaluation will be conducted.
To our knowledge, this is the first study investigating the implementation of decision coaches in German breast care centers.
Current Controlled Trials ISRCTN46305518 , date of registration: 5 June 2015.
乳腺癌女性希望参与治疗决策。指南已确认了知情共同决策的权利。然而,以往研究表明,由于医生资源有限、医患权力失衡以及缺乏循证患者信息,知情共同决策的实施并不理想。我们为原发性导管原位癌(DCIS)女性开发了一个知情共同决策项目。该项目由专业护士为女性提供决策指导,旨在支持她们参与决策并做出明智选择。在本试验中,将在乳腺护理中心对该知情共同决策项目进行评估。
方法/设计:将进行一项整群随机对照试验,以比较知情共同决策项目与标准护理。该项目包括一个循证患者决策辅助工具以及对医生(2小时)和专业乳腺护理及肿瘤护理护士(4天)进行知情共同决策培训。将纳入16家认证乳腺护理中心,招募192名原发性DCIS女性。主要结局是通过MAPPIN - 二元组(共享决策中“共享”的多焦点方法:观察者工具二元组)评估的患者参与共同决策的程度。次要终点包括MAPPIN量表的子测量指标(MAPPIN - 护士、MAPPIN - 医生、MAPPIN - 患者、MAPPIN - 护士问卷、MAPPIN - 患者问卷和MAPPIN - 医生问卷)、明智选择、决策冲突以及会诊时长。预计决策指导和提供循证患者决策辅助工具将增加患者在知情选择下参与决策的程度,并减少决策冲突和医生会诊时长。此外,还将进行一项配套的过程评估。
据我们所知,这是第一项在德国乳腺护理中心研究决策指导实施情况的研究。
当前受控试验ISRCTN46305518,注册日期:2015年6月5日。